Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z4SW
|
|||
Drug Name |
Benzimidazole derivative 8
|
|||
Synonyms |
PMID26936077-Compound-25
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
NEOPHARM CO.,LTD. ( ) GWAK, Hyung Sub KIM, Yong Zu KIM, Uk Il PARK, Byeong Deog PARK, Tae Kyo WOO, Sung Ho
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H25N3O
|
|||
Canonical SMILES |
CC1=CC(=CC=C1)CN2C(=NC3=C2C=CC(=C3)C(=O)N4CCCCC4)C
|
|||
InChI |
1S/C22H25N3O/c1-16-7-6-8-18(13-16)15-25-17(2)23-20-14-19(9-10-21(20)25)22(26)24-11-4-3-5-12-24/h6-10,13-14H,3-5,11-12,15H2,1-2H3
|
|||
InChIKey |
FWLBCCWBWAZRLY-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1234208-67-3
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Proteinase activated receptor 2 (PAR2) | Target Info | Antagonist | [1] |
Target's Patent Info | Proteinase activated receptor 2 (PAR2) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Inflammatory mediator regulation of TRP channels | ||||
African trypanosomiasis | ||||
Reactome | Peptide ligand-binding receptors | |||
G alpha (q) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.